TOKYO, Dec 9 (Reuters) - Japanese shares bounced back on Wednesday as positive COVID-19 vaccine news globally supported economic recovery hopes, while better-than-expected domestic machinery orders data also lifted investor sentiment.
The benchmark Nikkei share average rose 1.04% to 26,743.52 by the midday break, after declining for three straight sessions. The broader Topix added 0.88% to 1,774.24.
Overnight, the S&P and Nasdaq indexes notched record highs on a string of vaccine news and seeming progress on U.S. stimulus talks.
Hopes for a swift global economic recovery grew as Britain on Tuesday became the first Western nation to begin a wide vaccination campaign, and on encouraging COVID-19 vaccine news from Johnson & Johnson and Pfizer Inc.
Underpinning market sentiment further, data showed Japan’s core machinery orders rebounded sharply in October from the previous month’s drop.
The 17.1% jump was the largest month-on-month rise since comparable data became available in 2005, and far exceeded a 2.8% expansion forecast by economists in a Reuters poll.
The upbeat data sent shares of machinery companies higher. Komatsu climbed 2.58%, SMC Corporation added 2.27%, and Fanuc Corporation rose 2.02%.
Other sectors on the main bourse followed suit. Paper and pulp and textiles rose 2.45% and 1.13%, respectively.
Elsewhere, semiconductors tracked their U.S. peers higher. Advantest Corporation rose nearly 1.3%, while SUMCO spiked 4.38%
Tokyo Dome Corporation slipped nearly 4.5% after property developer Mitsui Fudosan said on Tuesday that Oasis Management was willing to tender shares in the company.
The Mothers Index of start-up firm shares bucked the overall trend to decline 1.96%.
Reprinted from Reuters. The copyright is reserved by the original author.
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
古いコメントはありません。ソファをつかむ最初のものになりましょう。